Benitec Limited (BLT.AX) Received Key Patent Notice of Intent To Re-Issue In the USA  
11/8/2010 1:21:53 PM

Melbourne, Nov 8, 2010 (ABN Newswire) - Benitec Limited (ASX:BLT) (PINK:BNIKF), the , the leading company in expressed gene silencing for human therapeutics, announced today that the United States Patent and Trademark Office (USPTO) has issued an official Notice of Intent to Issue an Ex Parte Re-examination Certificate for US Patent 6,573,099 ("the '099 Graham Patent"), the wide-ranging platform technology patent covering the use of expressed RNAi in human therapeutic applications.